Clinical Trial Update: Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma

View source ↗

Summary

A clinical trial is evaluating the prognostic impact of adjuvant therapy in primary hepatic sarcomatoid carcinoma. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Sarcomatoid Carcinoma
• Liver Cancer

Snippet

Sponsor: West China Hospital | Conditions: Sarcomatoid Carcinoma, Liver Cancer | Status: RECRUITING